Results 91 to 100 of about 9,578 (173)

Mucocutaneous leishmaniasis. [PDF]

BMJ, 1990
openaire   +2 more sources

A Review of the Progress in the Development of Leishmaniasis Vaccines [PDF]

Journal of Ardabil University of Medical Sciences
Leishmaniasis is a parasitic infectious disease that accounts for approximately one million new cases annually. The treatment of this disease is complex and costly, particularly in developing countries.
Narges Khaghanzadeh, Fatemeh Javadi, Afshin Samiei   +2 more
doaj  

Epidemiology of cutaneous and mucocutaneous leishmaniasis in Nicaragua. [PDF]

Parasite Epidemiol Control, 2020
Hernández-Bojorge SE, Blass-Alfaro GG, Rickloff MA, Gómez-Guerrero MJ, Izurieta R.   +4 more
europepmc   +1 more source

Interventions for American cutaneous and mucocutaneous leishmaniasis. [PDF]

Cochrane Database Syst Rev, 2020
Pinart M, Rueda JR, Romero GA, Pinzón-Flórez CE, Osorio-Arango K, Silveira Maia-Elkhoury AN, Reveiz L, Elias VM, Tweed JA.   +8 more
europepmc   +1 more source

American Tegumentary Leishmaniasis: Is Antimonial Treatment Outcome Related to Parasite Drug Susceptibility? [PDF]

, 2017
BackgroundAntimonials are the first drug of choice for the treatment of American tegumentary leishmaniasis (ATL); however, their efficacy is not predictable, and this may be linked to parasite drug resistance.
Adui, Vanessa, Arevalo, Jorge, Bermudez, Hernan, Chappuis, François, Croft, Simon, De Doncker, Simonne, Decuypere, Saskia, Dujardin, Jean-Claude, Llanos-Cuentas, Alejandro, Ortuño, Nimer, Ramirez, Luis, Yardley, Vanessa   +11 more
core  

Visceral Dissemination of Mucocutaneous Leishmaniasis in a Kidney Transplant Recipient. [PDF]

Pathogens, 2020
Marques N, Bustorff M, Cordeiro Da Silva A, Pinto AI, Santarém N, Ferreira F, Nunes A, Cerqueira A, Rocha A, Ferreira I, Tavares I, Santos J, Fonseca E, Moura C, Cerejeira A, Vide J, Cancela J, Sobrinho Simões J, Sampaio S.   +18 more
europepmc   +1 more source

Anti-leishmania igA immunoenzymatic assay in mucocutaneous leishmaniasis (Preliminary report) Ensaio Imunoenzimático de IgA Anti-Leishmânia na Leishmaniose mucocutânea (Nota Prévia)

Revista do Instituto de Medicina Tropical de São Paulo, 1984
The Authors describe an anti-Leishmania IgA-ELISA assay in mucocutaneous leishmaniasis. Increased titers were found in leishmaniasis patients, mainly in the first and second year of infection and in deep mycoses patients showing either mucosal ...
M. Carolina S. Guimarães, Antonio Walter Ferreira, Márcia B. de Carvalho, Beatriz J. Celeste, Luiz Carlos Cucé, Walter Belda Jr.   +5 more
doaj  

Mucocutaneous leishmaniasis in a cocaine user: diagnostic and therapeutic knowledge. [PDF]

Rev Soc Bras Med Trop, 2020
Sbroglio LL, Maiolini VM, Rabelo IMMA, Giraldelli GA, Tuccori LP, Cunha RG.   +5 more
europepmc   +1 more source

Mucocutaneous Leishmaniasis with Rare Manifestation in the Nasal Mucosa and Cartilage Bone Septal. [PDF]

Case Rep Infect Dis, 2020
Casalle N, de Barros Pinto Grifoni L, Bosco Mendes AC, Delort S, Massucato EMS.   +4 more
europepmc   +1 more source

Cutaneous and mucocutaneous leishmaniasis: experience of a Mediterranean hospital. [PDF]

Parasit Vectors, 2020
Garrido-Jareño M, Sahuquillo-Torralba A, Chouman-Arcas R, Castro-Hernández I, Molina-Moreno JM, Llavador-Ros M, Gómez-Ruiz MD, López-Hontangas JL, Botella-Estrada R, Salavert-Lleti M, Pemán-García J.   +10 more
europepmc   +1 more source